Small interfering RNA (siRNA) have attracted considerable attention, as compelling therapeutics providing safe and competent delivery systems are available. Dendrimers are emerging as appealing siRNA delivery vectors thanks to their unique, well-defined architecture and the resulting cooperativity and multivalency confined within a nanostructure. We have recently disclosed the structurally flexible fifth-generation TEA-core PAMAM dendrimer (G5) as an effective nanocarrier for delivery of sticky siRNA bearing long complementary sequence overhangs (dA)n/(dT)n (n = 5 or 7). Here, using combined experimental/computational approaches, we successfully clarified (i) the underlying mechanisms of interaction between the dendrimer nanovector G5 and s...
Dendrimer nanocarriers are unique hyper-branched polymers with biomolecule-like properties, represen...
13siGene therapy using small interfering RNA (siRNA) is emerging as a novel therapeutic approach to ...
siRNA delivery remains a major challenge in RNAi-based therapy. Here, we report for the first time t...
Small interfering RNA (siRNA) have attracted considerable attention, as compelling therapeutics prov...
5Small interfering RNAs (siRNAs) represent a new approach towards the inhibition of gene expression;...
Successful therapeutic implementation of RNA interference critically depends on systems able to safe...
Small interfering RNA (siRNA) constitutes an excellent way of knocking down genes. However, it requi...
Supramolecular dendrimers created from small amphiphilic dendrons are able to mimic covalently const...
International audienceSmall interfering RNA (siRNA) therapeutics hold great promise to treat a varie...
Successful achievement of RNA interference in therapeutic applications requires safe and efficient v...
5In part I of this review, the authors showed how poly(amidoamine) (PAMAM)-based dendrimers can be c...
Short double-stranded RNAs, which are known as short interfering RNA (siRNA), can be used to specifi...
RNA interference (RNAi) was first literaturally reported in 1998 and has become rapidly a promising ...
Therapeutics based on RNA interference mechanisms are highly promising for the management of several...
The lack of an appropriate intracellular delivery system for therapeutic nucleic acids (TNAs) is a m...
Dendrimer nanocarriers are unique hyper-branched polymers with biomolecule-like properties, represen...
13siGene therapy using small interfering RNA (siRNA) is emerging as a novel therapeutic approach to ...
siRNA delivery remains a major challenge in RNAi-based therapy. Here, we report for the first time t...
Small interfering RNA (siRNA) have attracted considerable attention, as compelling therapeutics prov...
5Small interfering RNAs (siRNAs) represent a new approach towards the inhibition of gene expression;...
Successful therapeutic implementation of RNA interference critically depends on systems able to safe...
Small interfering RNA (siRNA) constitutes an excellent way of knocking down genes. However, it requi...
Supramolecular dendrimers created from small amphiphilic dendrons are able to mimic covalently const...
International audienceSmall interfering RNA (siRNA) therapeutics hold great promise to treat a varie...
Successful achievement of RNA interference in therapeutic applications requires safe and efficient v...
5In part I of this review, the authors showed how poly(amidoamine) (PAMAM)-based dendrimers can be c...
Short double-stranded RNAs, which are known as short interfering RNA (siRNA), can be used to specifi...
RNA interference (RNAi) was first literaturally reported in 1998 and has become rapidly a promising ...
Therapeutics based on RNA interference mechanisms are highly promising for the management of several...
The lack of an appropriate intracellular delivery system for therapeutic nucleic acids (TNAs) is a m...
Dendrimer nanocarriers are unique hyper-branched polymers with biomolecule-like properties, represen...
13siGene therapy using small interfering RNA (siRNA) is emerging as a novel therapeutic approach to ...
siRNA delivery remains a major challenge in RNAi-based therapy. Here, we report for the first time t...